STOCK TITAN

Elanco Animal Health Incorporated - ELAN STOCK NEWS

Welcome to our dedicated page for Elanco Animal Health Incorporated news (Ticker: ELAN), a resource for investors and traders seeking the latest updates and insights on Elanco Animal Health Incorporated stock.

Elanco Animal Health Incorporated (NYSE: ELAN) is a global leader in animal health, committed to innovating and delivering products and services to improve the health and wellness of both farm animals and pets. Established with nearly 70 years of heritage, Elanco operates in over 90 countries with a diverse portfolio of approximately 200 brands. Their core mission is encapsulated in their vision: 'Food and Companionship Enriching Life,' which they pursue through three primary avenues:

  • Enhancing food security by improving the health and productivity of farm animals, thereby contributing to a safer, more affordable, and abundant food supply.
  • Helping pets live longer, healthier lives through advanced veterinary products.
  • Improving food safety standards globally.

Elanco’s dedication to animal health is reflected in their continuous innovation and quality systems, driven by a shared vision of enhancing life for animals and humans alike. This commitment is evident in their recent achievements and ongoing projects. For instance, Elanco's collaboration with Agtech company, Cattler, aims to provide data-driven solutions to cattle farmers, enhancing operational efficiency and productivity through services like Benchmark™ and Experior™.

Elanco's financial health is strong, with the company reporting consistent revenue growth and strategic investments aimed at future expansion. In their recent financial results, Elanco posted a 5% growth in the fourth quarter and strengthened their commercial infrastructure to support ongoing and future growth. They also announced the divestiture of their aqua business to streamline operations and focus on core areas, which is expected to reduce their debt leverage significantly by year-end.

Environmental sustainability is another critical focus for Elanco. Their recent partnership with Athian to create a livestock carbon insetting marketplace is a significant step towards reducing greenhouse gas emissions in the dairy and beef industries. Products like Bovaer®, which significantly reduce methane emissions from cattle, exemplify Elanco's commitment to sustainable farming practices.

Overall, Elanco continues to be at the forefront of animal health innovation, with substantial investments in R&D, strategic partnerships, and a clear commitment to sustainability and community health.

Rhea-AI Summary
Elanco Animal Health Incorporated (NYSE: ELAN) reported revenue of $1,068 million for the third quarter of 2023, representing 4% reported growth or 5% excluding the impact of foreign exchange rates. Reported Net Loss was $1,096 million, inclusive of a non-cash goodwill impairment charge of $1,042 million primarily related to increased long-term treasury rates. Adjusted EBITDA was $214 million, or 20.0% of Revenue. Updating full year 2023 guidance to reflect third quarter outperformance offset by expected unfavorable impact of foreign exchange rates: Revenue of $4,360 to $4,400 million, constant currency growth improves to flat to 1%.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.32%
Tags
-
Rhea-AI Summary
Athian announces the establishment of the first voluntary livestock carbon insetting marketplace, allowing farmers to monetize their greenhouse gas emission reductions. The marketplace will focus on reducing enteric methane emissions and improving feed utilization. Dairy farmers can implement sustainability interventions, measure their impact, and sell carbon credits. Companies in the dairy value chain can purchase these credits to contribute to their emissions reduction goals. The marketplace will expand to other livestock and poultry in the future.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.57%
Tags
none
-
Rhea-AI Summary
Elanco Animal Health to announce Q3 2023 financial results
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.82%
Tags
Rhea-AI Summary
Elanco Animal Health Incorporated is initiating a comprehensive governance review and seeking shareholder approval for amendments to its corporate governing documents at the 2024 Annual Meeting of Shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.19%
Tags
none
-
Rhea-AI Summary
Elanco Animal Health announces first shipments of Varenzin-CA1, the first treatment for non-regenerative anemia in cats with chronic kidney disease, are shipping to veterinary clinics.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.77%
Tags
none
-
Rhea-AI Summary
Elanco Animal Health to attend Morgan Stanley conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.91%
Tags
conferences
Rhea-AI Summary
ELAN: Elanco Animal Health Inc. Reports Q2 2023 Financial Results, Raises Full Year Guidance. Revenue at $1,057 million, with a net loss of $(97) million. Adjusted EBITDA at $222 million. Full year 2023 revenue guidance raised to $4,350 to $4,410 million. Positive EPA resolution on Seresto. Financial results impacted by ERP system commercial ordering blackout period for legacy Bayer Animal Health products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.03%
Tags
-
Rhea-AI Summary
Elanco Animal Health Incorporated (NYSE:ELAN) released its 2022 ESG Report, demonstrating commitment to ESG-related topics across its Healthy Purpose™ Pillars. The report highlights impactful initiatives such as reducing CO2e emissions by 7.2 million metric tons through the use of Rumensin™ and advancing diversity, equity, and inclusion efforts.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.12%
Tags
none
-
Rhea-AI Summary
Elanco Animal Health Incorporated (NYSE: ELAN) to announce Q2 2023 financial results on August 7, 2023. Conference call to provide detailed performance review. Live webcast available on Elanco's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.13%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.7%
Tags
none

FAQ

What is the current stock price of Elanco Animal Health Incorporated (ELAN)?

The current stock price of Elanco Animal Health Incorporated (ELAN) is $13.98 as of November 15, 2024.

What is the market cap of Elanco Animal Health Incorporated (ELAN)?

The market cap of Elanco Animal Health Incorporated (ELAN) is approximately 6.8B.

What is Elanco Animal Health's core mission?

Elanco's core mission is encapsulated in their vision: 'Food and Companionship Enriching Life,' which they pursue by enhancing food security, improving pet health, and elevating food safety standards globally.

In how many countries does Elanco operate?

Elanco operates in over 90 countries worldwide.

What recent collaborations has Elanco engaged in?

Elanco recently collaborated with Agtech company Cattler to provide data-driven solutions to cattle farmers through services like Benchmark™ and Experior™.

What is the significance of Elanco's partnership with Athian?

The partnership with Athian aims to create a livestock carbon insetting marketplace, reducing greenhouse gas emissions and promoting sustainable farming practices.

What are some of Elanco's notable products?

Elanco's notable products include Seresto®, Experior™, and Bovaer®, the latter being a methane-reducing feed ingredient for cattle.

How is Elanco addressing sustainability in animal farming?

Elanco addresses sustainability through innovative products like Bovaer®, which reduces methane emissions from cattle, and partnerships aimed at creating carbon insetting marketplaces.

What financial goals has Elanco set for 2024?

Elanco expects constant currency revenue growth of 2% to 3% for 2024, driven by new product launches and operational improvements. They also anticipate significant debt reduction through strategic divestitures.

How does Elanco contribute to food safety?

Elanco contributes to food safety by developing products that improve the health and performance of farm animals, thereby ensuring a safer and more reliable food supply.

What is Elanco's approach to innovation?

Elanco's approach to innovation involves continuous R&D investments, strategic partnerships, and the development of new products that address pressing issues in animal health and sustainability.

How does Elanco support the health and wellness of pets?

Elanco supports pet health through an extensive range of veterinary products designed to improve the quality and longevity of pets' lives.

Elanco Animal Health Incorporated

NYSE:ELAN

ELAN Rankings

ELAN Stock Data

6.81B
494.35M
0.66%
100.35%
2.33%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
GREENFIELD